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A b s t r a c t
Among the species belonging to the Aspergillus section Versicolores, Aspergillus creber has been poorly studied and still unexplored for 
its biological activities. The present study was undertaken to analyze A. creber extract and to evaluate its in vitro antimicrobial and anti-
oxidant activities. UHPLC-MS/MS analysis of A. creber extract allowed the characterization of five known fungal metabolites including: 
asperlactone, emodin, sterigmatocystin, deoxybrevianamide E, and norsolorinic acid. The highest antimicrobial activity was displayed 
against Candida albicans, with a mean strongest inhibition zone of 20.6 ± 0.8 mm, followed by Gram-positive drug-resistant bacteria. The 
MIC values of A. creber extract varied from 0.325 mg/ml to 5 mg/ml. A. creber extract was shown a potent antioxidant activity and a high 
level of phenolic compounds by recording 89.28% scavenging effect for DPPH free radical, 92.93% in ABTS assay, and 85.76 mg gallic acid 
equivalents/g extract in Folin-Ciocalteu assay. To our knowledge, this is the first study concerning biological and chemical activities of 
A. creber species. Based on the obtained results, A. creber could be a promising source of natural antimicrobial and antioxidant compounds.
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Introduction
Fungal secondary metabolites represent a diverse 
group of bioactive natural products often produced 
at a restricted part of the life cycle (Keller et al. 2005). 
Aspergillus species are among the major contributors 
to the secondary metabolites of fungal origin (Dewi 
et al. 2012; Bai et al. 2014). Although the functions of 
these compounds for the producing fungi are obscure 
or unknown, they confer important benefits to human-
kind as many of them have antibiotic and pharmaceuti-
cal activities (Yu and Keller 2005; Siddiquee et al. 2015). 
Isolation of a new fungal strain is often conducted to 
the identification of new natural products (Brakhage 
and Schroeckh 2011).
Aspergillus species assigned to section Versicolores 
are among the most ubiquitous fungi, frequently iso-
lated from environmental samples (Gautier et al. 2016). 
The important characteristics that render these species 
of interest to the scientific community are their preva-
lent in indoor environments, their capacity to produce 
sterigmatocystin (STC), a carcinogenic mycotoxin, and 
their diverse biotechnological applications (Siqueira 
et al. 2016). Before using molecular methods for species 
identification, isolates belonging to section Versicolores 
were commonly reported as A. versicolor (Despot et al. 
2016). In 2012, Jurjevic et al. revised the section Versi­
colores and accepted 13 species; among them, Aspergil­
lus creber was described for the first time as a  new 
species. Currently, the section Versicolores comprises 
17 distinct species (Despot et al. 2017); among them, 
A. versicolor and A. sydowii are still the most commonly 
reported and studied species (Siqueira et al. 2016). 
However, very few reports are available concerning the 
species A. creber and those reports were only concer-
ned with contamination by A. creber and its ability to 
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produce STC. A. creber was reported as the most preva-
lent species in indoor air environments in USA (Jurje-
vic et al. 2012) and in Italian libraries (Micheluz et al. 
2015). A. creber was also reported as among the lower 
producers of STC (Jurjevic et al. 2013).
Therefore, the lack of knowledge of this species 
recently assigned to section Versicolores has attracted 
our attention to more explore and study this species. 
In our research A. creber was assayed for its secondary 
metabolites diversity using UHPLC-MS/MS technique. 
Then, the antimicrobial activity of A. creber against 
some human pathogens and its ability to scavenge dif-
ferent free radicals, and to produce antioxidant com-
pounds were also evaluated to improve the knowledge 
of this species, which has never been tested before for 
its biological activities.
Experimental
Materials and Methods
Fungal strain. The strain of A. creber employed 
in this study was isolated from maize grains collected 
from Batna region, Northeast Algeria. Morphological 
identification of the selected strain was made follow-
ing the recommended method and media (Samson 
et al. 2014). Then, the identity was confirmed by the 
German Collection of Microorganisms and Cell Cul-
tures (DSMZ) using the analysis of the Internal Tran-
scribed Spacer rDNA region (ITS) and the calmodulin 
gene (CaM) sequences. The strain was kept on Potato 
Dext rose Agar (PDA) slants at 4°C in the fungal collec-
tion of the Laboratory de Mycologie, de Biotechnologie 
et de l’Activité Microbienne (LaMyBAM), University 
des Frères Mentouri Constantine-1.
Production and extraction of A. creber secondary 
metabolites. Under sterile conditions, a small amount 
of A. creber was transferred onto new PDA plates and 
incubated at 25°C until sporulation. The fungal spores 
were harvested by pouring 9 ml of sterile distilled water, 
containing 0.1% Tween 80, on the agar plate surfaces 
and transferred into sterile Falcon tubes. The prepared 
fungal suspension was inoculated aseptically in five 
1000 ml Erlenmeyer flasks [5% (v/v)], each contain-
ing 250 ml of Czapek-Dox broth supplemented with 
yeast extract (Slack et al. 2009). The Erlenmeyer flasks 
were covered with the aluminum foil and incubated at 
28 ± 2°C with shaking at 125 rpm for two weeks.
The culture broth was filtered, using Whatman filter 
paper number 1, to remove the mycelia. The filtered 
broth was extracted three times with equal volumes 
of ethyl acetate (EtOAc) and evaporated until dryness 
using a rotary evaporator at 45°C. The resulted ethyl 
acetate extract of the filtrate (EAF) was reconstituted 
in methanol to get a concentrated stock solution of 
200 mg/ml, which was used for further analysis.
Ultrahigh-performance liquid chromatography 
– tandem mass spectrometry (UHPLC-MS/MS) ana-
lysis of A. creber extract. A Q Exactive Orbitrap mass 
spectrometer (Thermo Fisher Scientific, Waltham, USA) 
coupled to a Dionex Ultimate 3000 UHPLC system 
(Thermo Fisher Scientific, Waltham, USA) via a HESI-II 
electrospray ionization (ESI) source was used for the 
analysis of EAF. A volume of 1 μl of EAF was injected 
on a Luna Omega C18 column (50 × 2.1 mm, 1.6 µm 
particle size). The column thermostat was maintained 
at 25°C. A mobile phase consisting of eluent A (0.1% 
formic acid in water, 5 mM ammonium formate) and 
eluent B (0.1% formic acid in methanol, 5 mM ammo-
nium formate) was used at a flow rate of 0.4 ml/min. 
The gradient elution was performed as follows: 0 min 
20% eluent B; 0.5 min 40% eluent B; 6 min 100% elu-
ent B; 8 min 20% eluent B; 10 min 20 % eluent B.
The Orbitrap mass spectrometer was operated in 
both positive and negative mode with the use of the 
following parameter settings: spray voltage, 4 kV; 
sheath gas (N2 > 95%), 35 arbitrary units; auxiliary gas 
(N2 > 95%), 10 arbitrary units; capillary temperature, 
290°C; S lens RF level, 50; heater temperature, 305°C. 
Two scan events were carried out, the LC-MS was used 
in full scan mode at a resolution of 70 000 fwhm (full 
width at half maximum) in the range m/z 90−1000 
without the use of any lock masses. The maximum 
injection time (MIT) was 100 ms with one micro scan, 
and the automatic gain control (AGC) target was set 
to 1e6. The MS/MS was performed in parallel reaction 
monitoring (PRM) mode, in order to obtain two prod-
uct ions for each target compound, at a resolution of 
35 000 fwhm with collision energy (CE) of 30, the AGC 
and MIT were set at 2e5 and 200 ms, respectively. The 
instrument control and data analysis were performed 
by Thermo Fisher Xcalibur v. 3.0.63 software.
Antimicrobial activity assay
Test microorganisms. Eight clinically isolated 
micro organisms, obtained from the laboratory of Clini-
cal Micro biology, University of Federico II Napoli-Italy, 
were used to evaluate the antimicrobial activity of EAF. 
Four Gram-negative pathogenic bacteria (Escherichia 
coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
and Salmonella Typhi) and two Gram-positive drug-
resistant bacteria (DRB, Staphylococcus aureus produc-
ing beta-lactamase (SABL) and methicillin-resistant 
Staphylococcus epidermidis (MRSE)) were used for the 
antibacterial tests. Two pathogenic yeasts (Candida 
albicans and Candida glabrata) were used for antican-
didal tests. Pathogenic bacteria were inoculated into the 
nutrient broth and incubated at 37°C for 24 h. Candida 
species were inoculated into Sabouraud Dextrose broth 
at 28°C for 48 h.
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Antimicrobial activity determination. Antimicro- 
bial activity of EAF against the test organisms was 
examined using disc diffusion method according to 
Turkoglu et al. (2007) with slight modification. Suspen-
sion of the organisms tested (0.5 McFarland standards) 
was spread on the sterile growth media plates contain-
ing Nutrient agar and Sabouraud Dextrose agar for 
bacteria and yeasts, respectively. Sterilized paper disks 
(6 mm) were impregnated with 20 μl of EAF and dried 
aseptically. The impregnated discs were placed on the 
surface of plates seeded with the test organisms and 
incubated at 37°C for 24 h for bacteria and at 28°C for 
48 h for yeasts. Both chloramphenicol (10 µg/disk) and 
ketoconazole (30 µg/disk) were employed as positive 
controls for pathogenic bacteria and Candida species, 
respectively. Similarly, 20 μl of methanol and clean disks 
(without solvent) were used as negative controls. All 
experiments were carried out in triplicate. After incuba-
tion, antimicrobial activity was determined by measur-
ing the diameter of inhibition zones around the discs.
Determination of minimum inhibitory concentra-
tion (MIC). The minimum inhibitory concentration 
(MIC) of EAF was carried out against the sensitive test 
microorganisms by using broth microdilution method 
following the recommendations of Clinical and Labora-
tory Standards Institute (CLSI) protocols for bacteria 
(CLSI 2012) and for yeasts (NCCLS 2002). Chloram-
phenicol and ketoconazole were used as a positive con-
trol. The MIC was taken as the lowest concentration at 
which no visible growth was observed.
Antioxidant analysis
2,2-diphenyl-1-picryl hydrazyl (DPPH) assay. 
The DPPH radical scavenging activity was determined 
according to Jakovljević et al. (2014). Different concen-
trations of EAF were prepared: 12.5, 25, 50, 100, 200, 
400 µg/ml. To 1 ml of DPPH solution, 1 ml of each con-
centration was added. After incubation for 30 min at 
37°C, the absorbance was measured at 517 nm against 
the blank. Ascorbic acid was used as positive control. 
The percentage of the DPPH scavenging activity was 
calculated using the formula:
% inhibition = [(A0 – A1)/A0] × 100
where A0 represents the absorbance of the blank sam-
ple, and A1 represents the absorbance of the mixture.
2,2’-azino-bis-3- ethylbenzthiazoline-6-sulphonic 
acid (ABTS) assay. Using the same concentrations, 
ABTS assay was used as reported by Dudonné et al. 
(2009). The ABTS radical cation (ABTS•+) stock solu-
tion was prepared by mixing 7 mM of ABTS with 2, 
45 mM of potassium persul fate. The mixture was left 
in the dark at room temperature for 12–16 h. For the 
study of EAF, the ABTS•+ solution was diluted with 
ethanol to an absorbance of 0.7 at 734 nm. To 3 ml of 
ABTS•+ diluted solution, 100 µl of each concentration 
was added, and the absorbance reading at 734 nm was 
taken at the end of the tenth minute. Percent inhibition 
of ABTS•+ was calculated using the previous formula.
Total phenolic content (TPC) assay. TPC of A. cre­
ber was determined using the Folin-Ciocalteu method. 
To 0.5 ml of EAF, 2.5 ml of Folin-Ciocalteu reagent 
was added. After 4 min, 2 ml of sodium carbonate 
(7.5%, w/v) were added, and the absorbance was meas-
ured at 760 nm after incubation for 2 h at room tem-
perature (Gan et al. 2010). The TPC of the extract was 
expressed as mg Gallic acid equivalent per g of extract 
(mg GAE/g extract).
Results
Fungal strain. Aspergillus isolate showed the typical 
macro- and micro-morphological features described for 
section Versicolores. For species designation, sequenc-
ing of the ITS rDNA and CaM gene followed by 
a BLAST search revealed that the isolated strain had 
a high identity (99%) with A. creber. Thus, according 
to these results, the strain was identified as A. creber 
and its sequences data were submitted at GenBank with 
accession numbers: MH796366 and MH796367.
UHPLC-MS/MS analysis. After two weeks of 
growth in the fermentation broth, the secondary meta-
bolites of A. creber were extracted, through EtOAc, fil-
tered and concentrated in vacuo to give EAF, which was 
subjected to UHPLC-MS/MS analysis. On the basis of 
the fungal metabolites list established by Lehner et al. 
(2011), molecular mass data, MS/MS analysis and refer-
ences, five known fungal metabolites were tentatively 
identified as asperlactone (1), emodin (5), sterigmato-
cystin (7), deoxybrevianamide E (9) and norsolorinic 
acid (10) (Table I) whereas five metabolites remained 
unidentifiable. The Total Ion Current (TIC) chroma-
tograms of the ten peaks of detected compounds are 
shown in Fig. 1.
Antimicrobial activity. Results obtained for the 
antimicrobial activity of EAF are shown in Table  II. 
In the case of bacteria, the highest zone of inhibition 
was displayed against Gram-positive DRB, including 
MRSE and SABL, followed by Gram-negative bacte-
ria K. pneumoniae and S. typhi with an inhibition zone 
ranged from 8.5 ± 0.6 to 14.0 ± 0.2 mm. No activity was 
observed against E. coli and P. aeruginosa at the concen-
tration used. In the case of yeasts, the EAF inhibited the 
growth of all tested yeasts (C. albicans and C. glabrata) 
with maximum inhibitory activity against C. albi­
cans, which displayed an important zone of inhibition 
(20.6 ± 0.8 mm).
Table II showed also the MIC values of A. creber 
extract against the tested organisms, which showed 
an inhibition zone in the disc diffusion assay. The 
EAF of A. creber showed MIC values ranging from 
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0.325 to 5 mg/ml. The higher MIC values were recorded 
against C. albicans (0.325 mg/ml) and Gram-positive 
DRB (0.625 mg/ml) whereas the lower MIC values 
were recorded against C. glabrata (1.25 mg/ml) and 
Gram-negative bacteria K. pneumoniae (2.5 mg/ml) 
and S. typhi (5 mg/ml).
Antioxidant analysis. In the DPPH assay, the EAF 
of A. creber extract demonstrated a dose-dependent 
scavenging activity and the highest decolorization was 
recorded at 400 µg/ml (Fig. 2a). In the ABTS assay, like 
the DPPH assay, the EAF exhibited a rich scavenging 
effect and the highest decolorization was also recorded 
at a concentration of 400 µg/ml (Fig. 2b). In both assays, 
the scavenging activity of EAF was slightly lower than 
  1  Asperlactone  [M+H]+  185.08081  141.05444, 113.05948  1.73  Vishwanath et al. 2009
  2  NI  [M+Na]+  211.06121  195.03455, 133.02816  1.78    –
  3  NI  [M+H]+  308.10992  280.95587, 145.10104  3.38    –
  4  NI  [M+H]+  327.04734  309.18594, 191.15396  4.28    –
  5  Emodin  [M+H]–  269.04590  ND  5.42  Sulyok et al. 2007; Lehner et al. 2011; 
      Micheluz et al. 2016
  6  NI  [M+H]+  251.09145  233.09526, 204.09319  5.49    –
  7  Sterigmatocystin  [M+H]+  325.07053  ND  6.62  Lehner et al. 2011; Micheluz et al. 2016
  8  NI  [M+Na]+  423.25041  405.27911, 239.14821  7.27    –
  9  Deoxybrevianamide E  [M+H]+  352.20352  ND  8.04  Lehner et al. 2011; Micheluz et al. 2016
10  Norsolorinic acid  [M+H]–  369.09892  ND  8.24  Micheluz et al. 2016
Table I
Metabolites of Aspergillus creber as determined by UHPLC-MS/MS. The metabolites were tentatively identified using molecular
mass data, MS/MS analysis and references.
a – Retention time; b – Reference; ND – not detected; NI – not identified
Peak
No.
Putative compound
name Adduction
Measured
mass (m/z) Productions (m/z)
tRa
(min) Ref
b
Bacteria
Escherichia coli 0 23.4 ± 0.3 –
Klebsiella pneumoniae 10.0 ± 0.3 25.0 ± 0.4 2.5
Pseudomonas aeruginosa 0 20.8 ± 0.4 –
Salmonella Typhi  8.5 ± 0.6 21.5 ± 0.3 5
SABLc 12.8 ± 0.3 19.8 ± 0.2 0.625
MRSEd 14.0 ± 0.2 19.2 ± 0.2 0.625
Yeasts
Candida albicans 20.6 ± 0.8 22.8 ± 0.4 0.325
Candida glabrata 13.0 ± 0.3 25.7 ± 0.5 1.25
Table II
Antimicrobial activity and minimum inhibitory concentration (MIC) of ethyl acetate extract
of Aspergillus creber against human pathogens.
a – Mean of three replicates (±) SD
b – Chloramphenicol and ketoconazole were used as the positive control for bacteria and yeasts respectively
c – Staphylococcus aureus producing beta lactamase
d – Methicillin resistant Staphylococcus epidermidis
0 – no zone of inhibition
Zone of inhibition (mm)a MIC of ethyl acetate
extract (mg/ml)Positive controlbEthyl acetate extract
DPPHa 89.28 ± 0.32 91.39 ± 0.39
ABTSa 92.93 ± 0.30 93.03 ± 0.45
Total phenolic content 85.76 ± 0.96 –(mg GAE/g)
Table III
Antioxidant activities of Aspergillus creber ethyl acetate extract
by DPPH and ABTS assays and its total phenolic content.
a – Percentage of inhibition at a concentration of 400 µg/ml.
 Values are mean of three replicates (±) SD
Activity Extract Ascorbic acida
that of ascorbic acid. In the Folin-Ciocalateu assay, the 
EAF showed a high level of total phenols (Table III).
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Discussion
Fungi are major producers of secondary metabolites 
with different biological activities and various chemi-
cal structures (Abo-Elmagd 2014). Until today, except 
for A. versicolor and A. sydowii, there is no thorough 
study on metabolic profiles for the Aspergillus species 
belonging to section Versicolores (Despot et al. 2017). 
Moreover, to our knowledge, there are no published 
reports recorded the antimicrobial and the antioxidant 
activities of A. creber.
Our study demonstrated that A. creber is able to 
produce a variety of secondary metabolites previously 
reported as potent biologically active compounds. 
The biological activity of asperlactone, a polyketide 
metabolite, had been established for the first time by 
Balcells et al. (1995). It was the first fungal compound 
that exhibited insect growth regulating activity in 
in vivo tests. Asperlactone has also been reported as 
a potent antibacterial and antifungal metabolite (Chen 
et al. 2014). Emodin is the most studied anthraquinone 
derivative for its diverse biological activities, including 
antibacterial (Hatano et al. 1999), antifungal (Kim et al. 
2004), antioxidant (Izhaki 2002), and anticancer prop-
erties (Cheshmi et al. 2017; Zhao et al. 2017). STC is 
a polyketide mycotoxin and a precursor of Aflatoxin B1 
(AFB1), however, its toxicity is lower than that of AFB1 
(Piontek et al. 2016). Deoxybrevianamide E is a pre-
nylated indole alkaloid that belongs to the family of bre-
vianamides. Although a variety of biological activities 
were exhibited by many brevianamides including anti-
bacterial, anti-insect pests and antitubercular properties 
(Xu et al. 2017) there are no reports in the literature 
concerning the bioactivities of deoxybrevianamide E. 
Norsolorinic acid is an anthraquinone derivative fungal 
metabolite. Wang et al. (2008) reported that norsolor-
inic acid has antiproliferative activity on T24 human 
bladder cancer cells.
Fig. 1. Total Ion Current chromatogram of Aspergillus creber extract obtained with UHPLC-MS/MS.
The retention times of the peaks (1–10) and their corresponding molecules names are presented in Table I.
Fig. 2. Free radical-scavenging activities of Aspergillus creber extract and ascorbic acid (400 µg/ml) measured (a), in DPPH assay
and (b), in ABTS assay.
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The ability of A. creber to produce STC is in accord-
ance with previous studies demonstrated that most 
of Aspergillus section Versicolores are STC producers 
(Jurjević et al. 2013, Despot et al. 2016). Moreover, our 
findings are in agreement with the study of Micheluz 
et al. (2016) reported that A. creber is able to produce 
emodin, STC, deoxybrevianamide E and norsolorinic 
acid. However, to our knowledge, this is the first report 
concerning the production of asperlactone from the 
species A. creber.
In the antimicrobial assays, our study indicated that 
A. creber exhibited more potent antibacterial activity 
against Gram-positive than Gram-negative bacteria. 
This variation of susceptibility could be attributed to 
the morphologic difference in the composition of their 
cellular membranes, which influences their reaction to 
antibacterial compounds (Valle Jr et al. 2015). In addi-
tion to its antibacterial activity, the EAF of A. creber 
exhibited higher anticandidal activity against Candida 
species. In the case of Candida species, ergosterol is the 
main target of antifungal drugs (Martins et al. 2015). 
These results are in contrast to the previous studies 
reported that the metabolites produced by A. versi­
color, the most studied species of Aspergillus section 
Versicolores, exhibited lower or no antibacterial and 
anticandidal activities (Zhuang et al. 2011; Song et al. 
2012; Ebada et al. 2018). Another attractive finding on 
A. creber was the higher MIC values of its ethyl acetate 
extract against C. albicans (0.312 mg/ml) and Gram-
positive DRB (0.625 mg/ml) since these species are the 
most common opportunistic pathogens (Martins et al. 
2015; Knafl et al. 2017). Moreover, our findings can be 
considered very promising since the extract was crude 
and obtained by using  non-optimized fermentation, 
which usually produces a poor yield of active com-
pounds (Noor Ifatul et al. 2016).
Our study also brings additional data on A. creber, 
since the antioxidant activity and the TPC of this spe-
cies were evaluated for the first time. The antioxidant 
ability of A. creber was tested using two different pro-
cedures, DPPH and ABTS assays. The DPPH assay 
is a widely used method that based on the reduction 
of the purple DPPH free radical to a yellow colored 
compound 1,1-diphenyl-2-picryl hydrazine (Floegel 
et al. 2011) whereas the ABTS assay is based on the 
reduction of the blue-green pre-formed ABTS•+ to the 
colorless ABTS form (Re et al. 1999). Thus, the higher 
scavenging activities of the EAF indicated its bioac-
tive potential to neutralize the DPPH free radicals and 
ABTS•+. These results are in agreement with many other 
studies reported the antioxidant potency of filamen-
tous fungi from different sources (Abo-Elmagd 2014; 
Kumaresan et al. 2015; Sharma 2015; Smith et al. 2015; 
Sugiharto et al. 2016). The slight difference between the 
antioxidant capacities of EAF and ascorbic acid may be 
explained either by the purity of ascorbic acid, whereas 
the extract of A. creber is a mixture of multiple com-
pounds or by the capacity of some compounds in the 
fungal extract to neutralize or to inhibit the effect of 
active compounds (Dhankhar et al. 2012). Moreover, 
our data revealed that A. creber is able to produce much 
higher content of phenols than the other filamentous 
fungi in the literature (Jakovljević et al. 2014; Smith 
et al. 2015; Sugiharto et al. 2016). Many previous studies 
attributed the antioxidant activity of filamentous fungi 
to their TPC (Abdel-Monem et al. 2013; Smith et al. 
2015, Nwobodo et al. 2017). In accordance with this, 
the higher percentages of inhibition of DPPH radical 
and ABTS•+ in our fungal extract might contribute to 
the high level of phenolic compounds.
In conclusion, UHPLC-MS/MS analysis revealed 
that A. creber could produce a variety of secondary 
metabolites including polyketides, anthraquinones, and 
alkaloids. Our findings suggest that A. creber might rep-
resent a novel source of natural bioactive products since 
we have demonstrated its ability to inhibit the growth 
of many pathogen microorganisms, mainly C. albicans 
and Gram-positive DRB, and its high antioxidant activ-
ity. Our work will increase the knowledge about the 
species A. creber newly described and serve as a prelude 
to a better understanding of the biology and the chem-
istry of its metabolites.
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